The Petri Dish: EyePoint CEO steps down; Sumitomo rebrands after gutting layoffs


Takeda has withdrawn its application to market its dengue virus vaccine in the U.S., and other biopharma news you may have missed.

Previous VC activity in Minnesota continues slow push compared to last year
Next TriHealth debuts new $25M ambulatory campus in Springfield Township